Those interested in holding Verastem (VSTM) should first ask themselves the two following questions. First question, what do you see as the future of oncology generally? Is the future in pinpoint chemical disruption of tumor growth, through whatever biochemical pathway it might be? Or is it in a more systemic immune system activation that enables the body to identify and attack cancer on its own? Second question, what is the purpose of speculative oncology stocks? Are they for trading price volatility, or for placing long-term bets on the success of various approaches to treatment?
From